Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Soheila Korourian

Concepts (304)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
30
2018
1222
2.130
Why?
Carcinoma, Ductal, Breast
9
2015
89
1.400
Why?
Mastectomy, Segmental
8
2015
95
1.140
Why?
Catheter Ablation
4
2014
125
0.980
Why?
Neoplasm Recurrence, Local
7
2014
647
0.920
Why?
Sentinel Lymph Node Biopsy
15
2017
119
0.910
Why?
Mastectomy
10
2018
147
0.870
Why?
Mammary Neoplasms, Experimental
7
2010
122
0.780
Why?
Soybean Proteins
4
2023
167
0.750
Why?
Biopsy, Needle
11
2017
181
0.750
Why?
Obesity
8
2023
1204
0.730
Why?
Carcinoma in Situ
3
2008
72
0.720
Why?
Lymph Nodes
12
2017
252
0.700
Why?
Caseins
4
2023
78
0.680
Why?
9,10-Dimethyl-1,2-benzanthracene
4
2015
50
0.660
Why?
Liver
9
2023
1150
0.620
Why?
DNA, Neoplasm
1
2018
146
0.540
Why?
Isoflavones
5
2023
88
0.540
Why?
Rats, Zucker
9
2023
73
0.480
Why?
Uterine Cervical Neoplasms
3
2007
301
0.440
Why?
Receptor, erbB-2
3
2018
79
0.430
Why?
Receptors, Estrogen
4
2018
134
0.420
Why?
Arginine
1
2015
178
0.410
Why?
Aged
32
2018
10429
0.410
Why?
Dietary Supplements
2
2015
479
0.410
Why?
Neoplasm Staging
15
2015
774
0.400
Why?
Female
51
2018
28782
0.390
Why?
Middle Aged
34
2018
13419
0.390
Why?
Mammary Neoplasms, Animal
2
2015
33
0.370
Why?
Diet
2
2015
610
0.360
Why?
Ultrasonography, Mammary
4
2015
61
0.350
Why?
Carcinogens
3
2015
194
0.340
Why?
Fatty Liver
3
2023
145
0.340
Why?
Antigens, Tumor-Associated, Carbohydrate
2
2008
24
0.340
Why?
Benz(a)Anthracenes
1
2010
3
0.330
Why?
Dehydroepiandrosterone
1
2010
12
0.330
Why?
Rats
15
2023
3162
0.320
Why?
Axilla
9
2017
92
0.310
Why?
Lymphatic Vessels
4
2014
45
0.310
Why?
Aged, 80 and over
15
2018
3494
0.300
Why?
Plant Lectins
1
2008
8
0.280
Why?
Carcinoma, Ductal
1
2008
7
0.280
Why?
Prognosis
11
2017
2118
0.280
Why?
Adult
25
2018
14534
0.280
Why?
Magnetic Resonance Imaging
4
2014
1583
0.270
Why?
Technetium Tc 99m Sulfur Colloid
6
2014
31
0.270
Why?
Receptors, Progesterone
4
2018
68
0.270
Why?
Humans
48
2024
53230
0.270
Why?
Clinical Competence
2
2024
406
0.260
Why?
Electrosurgery
1
2007
10
0.260
Why?
Thinness
3
2017
44
0.250
Why?
Lymphedema
5
2017
48
0.250
Why?
Lymphatic Metastasis
12
2015
211
0.250
Why?
Cytodiagnosis
4
2015
42
0.250
Why?
Prospective Studies
12
2017
2411
0.240
Why?
Animals
19
2023
13526
0.240
Why?
Follow-Up Studies
10
2015
2318
0.240
Why?
Combined Modality Therapy
5
2014
640
0.230
Why?
Nipples
5
2013
33
0.230
Why?
Biopsy, Fine-Needle
4
2024
104
0.230
Why?
Adenocarcinoma, Mucinous
1
2005
20
0.220
Why?
Ethanol
5
2010
338
0.220
Why?
Endometritis
1
2004
4
0.220
Why?
Competency-Based Education
1
2024
31
0.220
Why?
Radiopharmaceuticals
6
2014
198
0.210
Why?
Proteoglycans
1
2004
86
0.210
Why?
Carcinoma, Intraductal, Noninfiltrating
3
2013
47
0.200
Why?
Proliferating Cell Nuclear Antigen
1
2003
69
0.200
Why?
Laser Coagulation
1
2003
26
0.200
Why?
Fellowships and Scholarships
1
2024
124
0.200
Why?
Membrane Glycoproteins
1
2004
238
0.200
Why?
Lymph Node Excision
6
2017
132
0.190
Why?
Plasma Cells
1
2004
234
0.190
Why?
Neoplasm Invasiveness
5
2015
281
0.190
Why?
Carcinoma, Lobular
3
2015
32
0.190
Why?
Coloring Agents
4
2014
65
0.190
Why?
Mammaplasty
2
2013
43
0.180
Why?
Infant Food
1
2002
28
0.180
Why?
Uterine Cervical Dysplasia
3
2007
51
0.180
Why?
Monitoring, Intraoperative
3
2014
51
0.170
Why?
Ovarian Neoplasms
1
2005
459
0.170
Why?
Immunohistochemistry
9
2017
975
0.160
Why?
Biopsy
4
2007
600
0.160
Why?
Ultrasonography, Interventional
3
2011
138
0.160
Why?
Paraffin Embedding
2
2018
52
0.150
Why?
Body Weight
3
2017
524
0.150
Why?
Sensitivity and Specificity
8
2015
867
0.150
Why?
Lung Neoplasms
3
2015
645
0.150
Why?
Retrospective Studies
13
2015
6819
0.150
Why?
Neoplasm Grading
3
2014
128
0.150
Why?
Adolescent
8
2015
6907
0.150
Why?
Tissue Fixation
1
2018
35
0.140
Why?
Alanine Transaminase
3
2015
118
0.140
Why?
Specimen Handling
1
2018
63
0.140
Why?
Rats, Sprague-Dawley
7
2015
1544
0.120
Why?
Treatment Outcome
5
2017
5595
0.120
Why?
Pulmonary Medicine
1
2015
15
0.120
Why?
Protein Hydrolysates
1
2015
8
0.120
Why?
Kaplan-Meier Estimate
2
2014
487
0.120
Why?
Aspartate Aminotransferases
1
2015
46
0.120
Why?
Sulfotransferases
1
2015
38
0.110
Why?
Rosaniline Dyes
1
2014
8
0.110
Why?
Dermatologic Surgical Procedures
2
2013
35
0.110
Why?
Image-Guided Biopsy
1
2015
36
0.110
Why?
Melanoma
2
2011
277
0.110
Why?
Plant Extracts
1
2017
200
0.110
Why?
Vacuum
2
2011
11
0.110
Why?
Interleukin-6
1
2015
272
0.100
Why?
Ultrasonography, Doppler
1
2014
42
0.100
Why?
Young Adult
6
2015
4511
0.100
Why?
Tumor Necrosis Factor-alpha
1
2015
392
0.100
Why?
Patient Care Planning
1
2013
69
0.100
Why?
Intraoperative Care
2
2011
51
0.100
Why?
Carcinoma, Adenoid Cystic
1
2013
6
0.100
Why?
Disease-Free Survival
1
2014
466
0.100
Why?
Preoperative Care
1
2014
173
0.090
Why?
Skin Neoplasms
2
2011
500
0.090
Why?
Lymphography
1
2011
8
0.090
Why?
Image Processing, Computer-Assisted
2
2003
235
0.090
Why?
Frozen Sections
1
2011
13
0.080
Why?
Liver Neoplasms
2
2005
346
0.080
Why?
Cytoprotection
1
2010
32
0.080
Why?
DNA Methylation
1
2015
592
0.080
Why?
Male
10
2023
27435
0.080
Why?
Fatty Liver, Alcoholic
1
2010
7
0.080
Why?
Drug Evaluation, Preclinical
1
2010
142
0.080
Why?
Genistein
1
2010
45
0.080
Why?
Feasibility Studies
1
2011
411
0.080
Why?
Cell Line, Tumor
3
2010
1470
0.080
Why?
Hepatocytes
2
2008
188
0.070
Why?
Pilot Projects
1
2011
726
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1043
0.070
Why?
Radionuclide Imaging
4
2011
107
0.070
Why?
Hepatitis
1
2008
20
0.070
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2007
33
0.070
Why?
Cytokines
2
2008
627
0.070
Why?
Protons
1
2007
75
0.060
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2007
62
0.060
Why?
Ovariectomy
1
2007
114
0.060
Why?
Organ Size
1
2007
226
0.060
Why?
Oligosaccharides
1
2005
33
0.060
Why?
Cystadenocarcinoma, Papillary
1
2005
14
0.060
Why?
Antibodies, Neoplasm
1
2005
27
0.060
Why?
Omentum
1
2005
16
0.060
Why?
Aging
1
2010
714
0.060
Why?
Uterine Neoplasms
1
2005
57
0.060
Why?
Monosaccharide Transport Proteins
1
2004
14
0.060
Why?
Eosine Yellowish-(YS)
1
2004
6
0.050
Why?
Carcinoma, Small Cell
1
2004
26
0.050
Why?
Hematoxylin
1
2004
7
0.050
Why?
Syndecans
1
2004
37
0.050
Why?
Syndecan-1
1
2004
73
0.050
Why?
Endometrium
1
2004
43
0.050
Why?
Endotoxins
1
2004
23
0.050
Why?
Immunoenzyme Techniques
1
2004
134
0.050
Why?
Carbohydrates
1
2004
42
0.050
Why?
Lymphoma, Non-Hodgkin
1
2004
58
0.050
Why?
Pathology
1
2024
37
0.050
Why?
Liver Diseases, Alcoholic
1
2004
35
0.050
Why?
Cytological Techniques
1
2003
13
0.050
Why?
Apoproteins
1
2003
14
0.050
Why?
Neoplasms, Multiple Primary
1
2003
44
0.050
Why?
Dietary Fats
1
2004
133
0.050
Why?
Malondialdehyde
1
2003
55
0.050
Why?
Gene Expression Regulation
1
2008
1003
0.050
Why?
Gene Expression
2
2019
618
0.050
Why?
Fatty Acids
1
2004
154
0.050
Why?
Neoplasms
2
2004
1334
0.050
Why?
Cell Membrane
1
2004
233
0.050
Why?
Aldehydes
1
2003
81
0.050
Why?
Cytochrome P-450 CYP2E1
3
2010
111
0.050
Why?
Overweight
1
2005
232
0.050
Why?
Risk Factors
1
2011
4017
0.050
Why?
Surgical Instruments
1
2002
29
0.050
Why?
Foreign-Body Migration
1
2002
30
0.050
Why?
Breast Diseases
1
2002
25
0.050
Why?
Education, Medical, Graduate
1
2024
219
0.050
Why?
Hematoma
3
2010
67
0.050
Why?
Asia
1
2002
24
0.050
Why?
Chronic Disease
1
2004
580
0.050
Why?
Carcinoma, Squamous Cell
1
2004
332
0.040
Why?
Head and Neck Neoplasms
1
2004
291
0.040
Why?
Cost-Benefit Analysis
2
2015
274
0.040
Why?
Time Factors
1
2007
2991
0.040
Why?
Neoplasm Metastasis
2
2015
237
0.040
Why?
Health Status
1
2002
306
0.040
Why?
Cytokine Receptor Common beta Subunit
1
2019
2
0.040
Why?
Apoptosis
1
2005
1139
0.040
Why?
Methyltransferases
1
2019
28
0.040
Why?
Disease Progression
2
2015
880
0.040
Why?
Child, Preschool
1
2008
4162
0.040
Why?
Cohort Studies
2
2015
1557
0.040
Why?
Alcohol Dehydrogenase
2
2010
37
0.040
Why?
Arm
2
2009
47
0.040
Why?
Oxidative Stress
3
2010
819
0.040
Why?
Polymerase Chain Reaction
1
2019
452
0.040
Why?
Stereotaxic Techniques
2
2010
41
0.040
Why?
Anti-Bacterial Agents
1
2004
830
0.040
Why?
Risk Assessment
2
2017
1368
0.030
Why?
Adiponectin
1
2017
47
0.030
Why?
Disease Models, Animal
2
2015
1517
0.030
Why?
Reproducibility of Results
2
2015
1219
0.030
Why?
Injections, Intralesional
2
2008
32
0.030
Why?
Feces
1
2017
159
0.030
Why?
Phylogeny
1
2017
231
0.030
Why?
Lipid Metabolism
1
2017
189
0.030
Why?
Leptin
1
2017
151
0.030
Why?
Child
1
2008
7379
0.030
Why?
Cost Savings
1
2015
60
0.030
Why?
Protective Agents
1
2015
18
0.030
Why?
Taxoids
1
2015
38
0.030
Why?
MCF-7 Cells
1
2015
65
0.030
Why?
Mice, Inbred BALB C
2
2005
310
0.030
Why?
CpG Islands
1
2015
114
0.030
Why?
Insulin
1
2017
493
0.030
Why?
Infant, Newborn
1
2002
2913
0.030
Why?
Cyclophosphamide
1
2015
178
0.030
Why?
Tumor Cells, Cultured
1
2015
441
0.030
Why?
Touch
1
2013
23
0.030
Why?
Neoadjuvant Therapy
1
2015
124
0.030
Why?
Biopsy, Large-Core Needle
1
2013
34
0.030
Why?
Carcinoma
1
2015
136
0.030
Why?
Angiogenesis Inhibitors
1
2015
186
0.030
Why?
Infant
1
2002
3805
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2015
238
0.020
Why?
Radiotherapy, Adjuvant
1
2013
65
0.020
Why?
Hormones
1
2013
58
0.020
Why?
Chemotherapy, Adjuvant
1
2013
122
0.020
Why?
Injections, Intradermal
1
2011
13
0.020
Why?
X-Rays
1
2011
55
0.020
Why?
Antineoplastic Agents
2
2013
1232
0.020
Why?
Cicatrix
1
2011
43
0.020
Why?
United States
1
2002
5409
0.020
Why?
Intraoperative Period
1
2011
46
0.020
Why?
Diagnosis, Differential
2
2004
1038
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2015
868
0.020
Why?
Predictive Value of Tests
2
2004
934
0.020
Why?
Allyl Compounds
1
2010
11
0.020
Why?
Sulfides
1
2010
29
0.020
Why?
Survival Rate
1
2012
949
0.020
Why?
Chemokines
1
2010
78
0.020
Why?
Transforming Growth Factor beta1
1
2010
61
0.020
Why?
Double-Blind Method
1
2011
729
0.020
Why?
Mammary Glands, Animal
1
2010
68
0.020
Why?
Endoplasmic Reticulum
1
2010
99
0.020
Why?
Cell Division
1
2010
289
0.020
Why?
Pyrazoles
1
2010
123
0.020
Why?
Pregnancy
1
2015
2608
0.020
Why?
Tissue Extracts
1
2007
13
0.020
Why?
Enzyme Inhibitors
1
2010
371
0.020
Why?
Least-Squares Analysis
1
2007
44
0.020
Why?
Biotransformation
1
2007
84
0.020
Why?
Survival Analysis
1
2009
659
0.020
Why?
Electrocoagulation
1
2007
12
0.020
Why?
Solubility
1
2007
83
0.020
Why?
Observer Variation
1
2007
138
0.020
Why?
Staining and Labeling
1
2007
94
0.020
Why?
Enteral Nutrition
1
2008
157
0.020
Why?
Positron-Emission Tomography
1
2008
298
0.020
Why?
E-Selectin
1
2005
11
0.010
Why?
Body Weights and Measures
1
2005
17
0.010
Why?
Wheat Germ Agglutinins
1
2005
3
0.010
Why?
Vaccines, DNA
1
2005
11
0.010
Why?
Vaccines, Subunit
1
2005
15
0.010
Why?
Gadolinium
1
2005
47
0.010
Why?
Cross Reactions
1
2005
42
0.010
Why?
Growth Inhibitors
1
2005
26
0.010
Why?
Cytotoxicity, Immunologic
1
2005
55
0.010
Why?
Ligands
1
2005
203
0.010
Why?
Gene Amplification
1
2005
58
0.010
Why?
Mice
2
2005
5982
0.010
Why?
Glucose Transporter Type 1
1
2004
17
0.010
Why?
Imaging, Three-Dimensional
1
2005
145
0.010
Why?
Free Radicals
1
2004
27
0.010
Why?
Sampling Studies
1
2004
38
0.010
Why?
In Situ Hybridization, Fluorescence
1
2005
266
0.010
Why?
Enzyme Induction
1
2004
75
0.010
Why?
Contrast Media
1
2005
178
0.010
Why?
Corn Oil
1
2004
12
0.010
Why?
Eye Neoplasms
1
2004
9
0.010
Why?
Hyperplasia
1
2004
98
0.010
Why?
MART-1 Antigen
1
2004
12
0.010
Why?
Amino Acid Sequence
1
2005
563
0.010
Why?
Species Specificity
1
2004
191
0.010
Why?
Cell Proliferation
1
2008
1031
0.010
Why?
Necrosis
1
2004
169
0.010
Why?
Molecular Sequence Data
1
2005
759
0.010
Why?
Rats, Wistar
1
2004
192
0.010
Why?
Injections
1
2003
59
0.010
Why?
Dietary Carbohydrates
1
2004
91
0.010
Why?
Regression Analysis
1
2004
391
0.010
Why?
Cytoplasm
1
2004
93
0.010
Why?
Cytochrome P-450 Enzyme System
1
2004
191
0.010
Why?
Cell Nucleus
1
2004
187
0.010
Why?
Antigens, Neoplasm
1
2004
146
0.010
Why?
Energy Intake
1
2004
186
0.010
Why?
Multivariate Analysis
1
2004
598
0.010
Why?
Glutathione
1
2004
303
0.010
Why?
Sex Characteristics
1
2004
204
0.010
Why?
Antioxidants
1
2004
264
0.010
Why?
Confidence Intervals
1
2002
158
0.010
Why?
Models, Theoretical
1
2002
180
0.010
Why?
Neoplasm Proteins
1
2004
330
0.010
Why?
Reoperation
1
2002
476
0.010
Why?
Korourian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description